BMS-986259

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986259, covering 2022-08-04 to 2022-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety of BMS-986259 in Participants With Post-Acute Decompensated Heart Failure [Phase 2]